Cerebral venous sinus thrombosis in pregnancy and puerperium: A pooled, systematic review. (May 2017)

• Record Type: Journal Article
• Authors: Kashkoush, Ahmed I.; Ma, Henry; Agarwal, Nitin; Panczykowski, David; Tonetti, Daniel; Weiner, Gregory M.; Ares, William; Kenmuir, Cynthia; Jadhav, Ashutosh; Jovin, Tudor; Jankowitz, Brian T.; Gross, Bradley A.
• Is Part Of: Journal of clinical neuroscience. Volume 39(2017:May)
• Page Start: 9
• Page End: 15
• Publication Date: 2017-05
• Subjects: Cerebral venous sinus thrombosis -- Sinus thrombosis -- Stroke -- Pregnancy -- Endovascular -- Thrombectomy; Brain -- Surgery -- Periodicals; Neurosciences -- Periodicals; Nervous system -- Surgery -- Periodicals; Brain -- surgery -- Periodicals; Neurosurgical Procedures -- Periodicals; Neurosciences -- Periodicals; Electronic journals; 616.8
• DOI: 10.1016/j.jocn.2017.02.046
• Languages: English
• ISSNs: 0967-5868

Abstract

Highlights: Long-term outcomes in patients presenting with headache alone is excellent. Coma or obtundation predicts long-term deficits following intervention. Endovascular therapy may be beneficial in moribund patients. Abstract: Pregnancy and puerperium are risk factors for cerebral venous sinus thrombosis (CVST); however studies describing diagnosis and management in this population are limited. The objective of this study was to amalgamate published case reports and series regarding diagnosis and management of CVST in pregnancy and puerperium. Searches of PubMed and the Cochrane library were performed using search terms "pregnancy"/"puerperium" and "sinus occlusion"/"sinus thrombosis". Studies were included in our pooled analysis if they included individual patient symptoms, management approach and follow-up condition. Multivariate regression was utilized to assess the effect of non-modifiable factors on excellent outcome (mRS 0). Sixty-six patients were included. Mean duration of symptom onset to diagnosis was 5.9 days (95% CI 4.2–7.6). Clot involvement of the superior sagittal sinus was seen in 67% of cases, the transverse/sigmoid in 64% and of the deep venous system in 15% of cases. Management approaches included anticoagulation (91% of patients), IA (intra-arterial) thrombolysis alone (26%), and IA thrombectomy with IA thrombolysis (8%). Fifty-nine percent of patients were mRS 0 at follow-up; 94% were mRS 0-2. Presentation with headache alone was associated with excellent outcome on multivariate analysis ( p = 0.04); coma/obtundation predicted against excellent outcome ( p = 0.03). As compared to IA thrombolysis alone, patients undergoing IA thrombolysis with IA thrombectomy demonstrated a trend toward better outcome ( p = 0.10).